Subscribe Subscribe   Find us on Twitter Follow POL on Twitter  



Pfizer pulls Bextra

Today, drug manufacturer Pfizer has pulled its pain medication Bextra from the market. Bextra is a COX-2 inhibitor, the same class of drug as Merck drug Vioxx, which was pulled last fall (and, more recently, approved for reintroduction). (For more on Vioxx, see Feb. 8, Jan. 27, Jan. 5, Dec. 31, Dec. 27, Dec. 18, Dec. 2, Nov. 18 (II), Nov. 18 (I), Nov. 8, Oct. 4). As lawyers are likely to pile on to this one, as well, expect a lot more to follow. (Note: unlike the Vioxx case, in which Merck pulled the drug without FDA prompting, the FDA ordered this decision, with which Pfizer has said it "respectfully disagrees.")



Rafael Mangual
Project Manager,
Legal Policy

Katherine Lazarski
Manhattan Institute


Published by the Manhattan Institute

The Manhattan Insitute's Center for Legal Policy.